ARTV vs BA · rev $251.0K vs P/E 89, rev $89.46B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ARTV currently screens at market cap $37.3M. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ARTV and BA stock pages for the full models.
Not investment advice.